CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Operating Expenses:
Research and development	$ 1,185,384	$ 1,382,995
Selling and marketing
General and administrative	$ 2,697,690	$ 3,016,684
Total Operating Expenses	3,883,074	4,399,679
Operating Loss	$ (3,883,074)	(4,399,679)
Other Income (Expense):
Income from assets held for investment, net (Note 3)		193,607
Interest income	$ 6	586
Interest expense	(350,028)	(321,670)
Change in fair value of derivative liabilities (Note 9)	1,488,237	4,525,739
Net Loss	(2,193,358)	(1,417)
Preferred Stock Dividend (Note 8)	339,583	2,058,329
Net Loss Available to Common Stockholders	$ (2,532,941)	$ (2,059,746)
Basic and Diluted Net Loss Per Common Share (Note 12) (in dollars per share)	$ (0.003)	$ (0.003)
Weighted Average Number of Shares of Common Stock Outstanding - basic and diluted (Note 12) (in shares)	793,346,901	679,630,247
Other Comprehensive Income:
Net Loss	$ (2,193,358)	$ (1,417)
Change in foreign currency translation adjustments	36,663	6,971
Comprehensive (Loss)/Income	(2,156,695)	5,554
Preferred Stock Dividend (Note 8)	339,583	2,058,329
Comprehensive Loss Available to Common Stockholders	$ (2,496,278)	$ (2,052,775)